That FDA statement today is going to look very sad

That FDA statement today is going to look very sad for the FDA when this chapter in history is written IMO because:

they can't get the facts on CD10 endpoints right,
they don't mention the amazing safety profile,
they didn't allow age-adjustment for the unbalanced enrolled # of patients by age in the various arms of the study,
they ignore the unnecessary limiting of CD12 to two weeks,
they don't mention it works better than other EUA covid drugs,
and the FDA's timing today with domestic trading & in light of company developments overseas in India, Brazil and the Philippines, Canada and the UK is fascinating.

In the meantime, IMO Cytodyn:
has plenty of data to know what new trial protocols for covid severe & critical cases will shock the world in the Brazil trials,
In a few weeks Cytodyn will know what trial protocols for covid longhaulers will shock the world in a future Phase 3 trial.
data from the Philippines is coming
data from the US longhaulers is coming
a big company in India took Cytodyn seriously

JMO

There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.